Lansforsakringar Fondforvaltning’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.8M Sell
414,276
-51
-0% -$3.93K 0.16% 116
2025
Q4
$32.9M Buy
414,327
+15,715
+4% +$1.24M 0.16% 113
2025
Q3
$30.1M Buy
398,612
+8,992
+2% +$616K 0.16% 120
2025
Q2
$26.9M Sell
389,620
-21,742
-5% -$1.43M 0.15% 119
2025
Q1
$27.9M Sell
411,362
-11,537
-3% -$690K 0.17% 112
2024
Q4
$19M Buy
+422,899
New +$23.7M 0.11% 163

Other funds holding CVS

Lansforsakringar Fondforvaltning's CVS Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its CVS Health (CVS) stake by 0.01% in Q1 2026, selling an estimated $3.93K and leaving 414,276 shares worth $29.8M. The position accounts for 0.16% of the portfolio, ranked #116.

Lansforsakringar Fondforvaltning first reported a position in CVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $32.9M in Q4 2025. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 414,276 shares of CVS Health worth $29.8M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 51 CVS Health shares in Q1 2026, an estimated $3.93K.
  • CVS Health made up 0.16% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #116 holding.
  • Lansforsakringar Fondforvaltning first reported a position in CVS Health in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's CVS Health position peaked at $32.9M in Q4 2025.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.